Effect of amiodarone +/- diltiazem +/- beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting

Am J Cardiol. 2002 May 1;89(9):1126-8. doi: 10.1016/s0002-9149(02)02287-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / economics*
  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Amiodarone / economics*
  • Amiodarone / therapeutic use
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / prevention & control*
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / economics
  • Coronary Artery Bypass* / statistics & numerical data
  • Coronary Disease / surgery
  • Critical Pathways / economics
  • Diltiazem / economics*
  • Diltiazem / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Hospital Costs* / statistics & numerical data
  • Humans
  • Incidence
  • Length of Stay* / economics
  • Length of Stay* / statistics & numerical data
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care / statistics & numerical data
  • Postoperative Period
  • Preoperative Care
  • Vasodilator Agents / economics
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Vasodilator Agents
  • Diltiazem
  • Amiodarone